Currently, there are 114.16M common shares owned by the public and among those 109.71M shares have been available to trade.
The company’s stock has a 5-day price change of -9.09% and 17.71% over the past three months. MLI shares are trading 74.23% year to date (YTD), with the 12-month market performance up to 99.20% higher. It has a 12-month low price of $40.43 and touched a high of $96.81 over the same period. MLI has an average intraday trading volume of 821.17K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.31%, 2.92%, and 28.56% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Mueller Industries, Inc (NYSE: MLI) shares accounts for 93.16% of the company’s 114.16M shares outstanding.
It has a market capitalization of $8.96B and a beta (3y monthly) value of 1.03. The stock’s trailing 12-month PE ratio is 15.96, while the earnings-per-share (ttm) stands at $5.15. The company has a PEG of 1.33 and a Quick Ratio of 3.85 with the debt-to-equity ratio at 0.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.88% over the week and 3.15% over the month.
Earnings per share for the fiscal year are expected to decrease by -1.89%, and 1.92% over the next financial year. EPS should shrink at an annualized rate of 12.00% over the next five years, compared to 42.21% over the past 5-year period.
Boenning & Scattergood coverage for the Mueller Industries, Inc (MLI) stock in a research note released on December 14, 2020 offered a Outperform rating with a price target of $55. Monness Crespi & Hardt on their part issued Neutral rating on November 01, 2013.
